Literature DB >> 7573353

Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.

G H Smith1, R Sharp, E C Kordon, C Jhappan, G Merlino.   

Abstract

Transforming growth factor (TGF)-alpha stimulates the growth and development of mammary epithelial cells and is implicated in the pathogenesis of human breast cancer. In this report we evaluate the consequences of overexpressing TGF-alpha in the mammary gland of transgenic mice and examine associated cellular mechanisms. When operating on a FVB/N genetic background (line MT100), TGF-alpha induced the stochastic development of mammary adenomas and adenocarcinomas f secretory epithelial origin in 64% of multiparous females. In contrast, tumors were exceedingly rare in virgin MT100 females, MT100 males, and multiparous FVB/N females. In MT100 females multiple foci of hyperplastic secretory lesions preceded the development of frank tumors; these initial lesions appeared during the involution period after the first lactation. Serial transplantation of these hyperplasias indicated an absence of proliferative immortality. Nevertheless, they gave rise to tumors at a low frequency and after a prolonged latency in virgin hosts; in multiparous hosts, tumors developed earlier and at a high incidence. The TGF-alpha transgene was highly expressed in hyperplasias and tumors but not in virgin and nonlesion-bearing tissue, suggesting that TGF-alpha overexpression provides a selective growth advantage. TGF-alpha also induced at lactation a 6.4-fold increase in DNA synthesis in MT100 epithelial cells, many of which were binucleated. MT100 mammary tissue experienced an obvious delay in involution, resulting in the postlactational survival of a significant population of unregressed secretory epithelial cells. In contrast, another line of transgenic mice on a CD-1 genetic background (MT42), in which TGF-alpha overexpression induced liver but not mammary tumors, failed to demonstrate postlactational epithelial cell survival. These data show that TGF-alpha promotes mammary tumorigenesis in multiparous MT100 mice by stimulating secretory epithelial cell proliferation during lactation and prolonging survival during involution. These points support the notion that TGF-alpha can act as a mitogen and also as a differentiation factor in mammary epithelium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7573353      PMCID: PMC1871019     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

Review 1.  Apoptosis: a different type of cell death.

Authors:  L E Gerschenson; R J Rotello
Journal:  FASEB J       Date:  1992-04       Impact factor: 5.191

2.  Normal and neoplastic mammary gland growth in MMTV/TGF alpha transgenic mice.

Authors:  M Mizuno; K Yamamoto; S Sakamoto; T Mori; T Harigaya; H Nagasawa
Journal:  In Vivo       Date:  1994 May-Jun       Impact factor: 2.155

Review 3.  Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers.

Authors:  S Sell; G B Pierce
Journal:  Lab Invest       Date:  1994-01       Impact factor: 5.662

4.  Hypertrophic gastropathy resembling Ménétrier's disease in transgenic mice overexpressing transforming growth factor alpha in the stomach.

Authors:  H Takagi; C Jhappan; R Sharp; G Merlino
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 5.  Apoptosis. Its significance in cancer and cancer therapy.

Authors:  J F Kerr; C M Winterford; B V Harmon
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

6.  Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.

Authors:  S Tamano; G T Merlino; J M Ward
Journal:  Carcinogenesis       Date:  1994-09       Impact factor: 4.944

7.  Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor alpha.

Authors:  D E Bockman; G Merlino
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

8.  Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells.

Authors:  I Perroteau; D Salomon; M DeBortoli; W Kidwell; P Hazarika; R Pardue; J Dedman; J Tam
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 9.  Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.

Authors:  N Normanno; F Ciardiello; R Brandt; D S Salomon
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

10.  Apoptotic cell death and tissue remodelling during mouse mammary gland involution.

Authors:  R Strange; F Li; S Saurer; A Burkhardt; R R Friis
Journal:  Development       Date:  1992-05       Impact factor: 6.868

View more
  19 in total

1.  Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin.

Authors:  T Wrone-Smith; R S Mitra; C B Thompson; R Jasty; V P Castle; B J Nickoloff
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

2.  Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor.

Authors:  H Takayama; W J LaRochelle; R Sharp; T Otsuka; P Kriebel; M Anver; S A Aaronson; G Merlino
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats.

Authors:  B R Davies; A M Platt-Higgins; G Schmidt; P S Rudland
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 4.  The comparative pathology of human and mouse mammary glands.

Authors:  R D Cardiff; S R Wellings
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

5.  Prolactin potentiates transforming growth factor alpha induction of mammary neoplasia in transgenic mice.

Authors:  Lisa M Arendt; Teresa A Rose-Hellekant; Eric P Sandgren; Linda A Schuler
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 6.  Growth factors, apoptosis, and survival of mammary epithelial cells.

Authors:  E C Rosfjord; R B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

7.  Mammary carcinogenesis is preceded by altered epithelial cell turnover in transforming growth factor-alpha and c-myc transgenic mice.

Authors:  Teresa A Rose-Hellekant; Kristin M Wentworth; Sarah Nikolai; Donald W Kundel; Eric P Sandgren
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

8.  Dominant negative Ras enhances lactogenic hormone-induced differentiation by blocking activation of the Raf-Mek-Erk signal transduction pathway.

Authors:  Maria Grazia Cerrito; Traci Galbaugh; Weihan Wang; Treasa Chopp; David Salomon; Mary Lou Cutler
Journal:  J Cell Physiol       Date:  2004-11       Impact factor: 6.384

Review 9.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

Review 10.  Transgenic models to study actions of prolactin in mammary neoplasia.

Authors:  Lisa M Arendt; Linda A Schuler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.